HOME >> MEDICINE >> NEWS
Womens stroke symptoms differ from mens, often arent 'traditional' signs, study finds

ANN ARBOR, MI A new study documents for the first time a significant difference in the way women and men describe their symptoms while they're having a stroke. And that difference may be affecting how women receive emergency stroke treatment.

On the whole, the study found, women were 62 percent more likely than men to say they were feeling sensations that aren't on the list of "traditional" stroke symptoms.

Because emergency responders and emergency room doctors often go by patients' descriptions and the traditional symptom list when trying to diagnose and treat a suspected stroke, women's symptoms may be overlooked during the precious hours when stroke therapies work best, the researchers say. Delays in treatment with clot-busting drugs can lead to long-term disability or even death from a stroke.

The study, published in the November issue of the Annals of Emergency Medicine by stroke specialists from the University of Michigan Health System and the University of Texas at Houston, concludes that recognition of the symptom differences could help women be evaluated and treated faster and more effectively.

The new results, from the TLL Temple Foundation Stroke Project, may help explain findings from other research showing that women often don't get stroke treatment as quickly as men.

"Our findings have important consequences for stroke diagnosis and treatment," says senior author Lewis Morgenstern, M.D. "All stroke treatments are time-dependent, so if women are not diagnosed promptly, it will slow down the effort to treat them." Morgenstern directs the U-M Stroke Program and is an associate professor of Neurology, Epidemiology, Emergency Medicine and Neurosurgery at the U-M Medical School and School of Public Health.

He adds, "These differences are both biologically interesting and socially consequential. They are important to medical education, too, because often medical students and others are trained that stroke is
'"/>

Contact: Kara Gavin
kegavin@umich.edu
734-764-2220
University of Michigan Health System
25-Oct-2002


Page: 1 2 3 4

Related medicine news :

1. Obesity among African-American stroke survivors increases risk factors for recurrent stroke
2. Neurobehavioral function during coma, stroke rehabilitation effective for elderly
3. Blood pressure treatment could cut risk of strokes and heart attacks
4. Mayo Clinic develops first genomic-based test to predict stroke from ruptured brain aneurysm
5. Folic acid and vitamin B12 decrease risk of hip fracture in stroke patients
6. Columbia study finds hemophilia therapy dramatically improves outcomes for bleeding stroke
7. New device will help stroke victims recovery
8. Regular cannabis may increase risk of stroke in young users
9. Viagra used in stroke recovery study
10. COX-2 product offers good and bad news in test tube strokes
11. Mount Sinai stroke prevention trial published in JAMA

Post Your Comments:
(Date:8/3/2015)... ... 03, 2015 , ... Sensato and Divurgent ... Healthcare Systems” This three-day, highly interactive and immersive workshop, has been developed ... to the tactics, techniques and practices required to design and develop highly secure ...
(Date:8/3/2015)... ... , ... A July 13 article from The Daily Mail titled "Jab ... That Can Last 'For Five Weeks'" discusses the use of stem cells to ... that harvesting stem cell-rich bone marrow from the hip, known as bone marrow stromal ...
(Date:8/3/2015)... San Ramon, CA (PRWEB) , ... August 03, ... ... a leading global insurance brokerage firm, announced today that Joe Williams has joined ... business development, sales, and delivering HUB's differentiated service model to his clients. Mr. ...
(Date:8/3/2015)... ... August 03, 2015 , ... ... management and investigative services, has introduced a new logo and comprehensive brand ... that improve business outcomes for its customers. EMSI’s new tagline, “Powerful Information. ...
(Date:8/2/2015)... Provo, Utah (PRWEB) , ... August 03, 2015 ... ... and corporate training, will be attending and exhibiting at the Association for Healthcare ... August 7-8. , “We are pleased for the opportunity the AHDI conference ...
Breaking Medicine News(10 mins):Health News:Sensato and Divurgent are pleased to announce the development of it’s new program “Designing Secure Healthcare Systems” 2Health News:Sensato and Divurgent are pleased to announce the development of it’s new program “Designing Secure Healthcare Systems” 3Health News:Sensato and Divurgent are pleased to announce the development of it’s new program “Designing Secure Healthcare Systems” 4Health News:Los Angeles Spine Surgeon Gives Insight into How Stem Cells Can Relieve Back Pain 2Health News:Los Angeles Spine Surgeon Gives Insight into How Stem Cells Can Relieve Back Pain 3Health News:HUB International Insurance Services Announces Joe Williams Has Joined its Northern California Employee Benefits Division 2Health News:EMSI Announces New Branding: Powerful Information. Improved Outcomes. 2Health News:Career Step to Exhibit at AHDI Conference in Alexandria, Virginia on August 7-8 2
(Date:8/3/2015)... FLORHAM PARK, N.J. , Aug. 3, 2015 /PRNewswire/ ... primary and secondary endpoints in a phase III study ... in adult patients with chronic non-cancer pain. Naldemedine is ... This is the third Phase III trial in which ... Study results showed that a 0.2 mg tablet ...
(Date:8/3/2015)... Israel , August 3, 2015 ... it received the statistical analysis of results from a study ... the BVX-005 phase II trial which took place in 2012, ... not exist at the time of the study- in particular ... the epidemic in the United States ...
(Date:8/3/2015)... Minn. , Aug. 3, 2015  EnteroMedics Inc. (NASDAQ: ... neuroblocking therapy to treat obesity, metabolic diseases and other ... has been appointed to the Board of Directors, ... a Class II Director until the 2018 annual meeting ... Ms. McDougal has served in an executive capacity ...
Breaking Medicine Technology:Naldemedine Meets Primary Endpoint In Phase 3 Study For The Treatment Of Opioid-Induced Constipation 2Naldemedine Meets Primary Endpoint In Phase 3 Study For The Treatment Of Opioid-Induced Constipation 3Naldemedine Meets Primary Endpoint In Phase 3 Study For The Treatment Of Opioid-Induced Constipation 4Independent Results Show that BiondVax's Universal Flu Vaccine Administered in a Trial 3 Years ago Improves Immunogenicity Against Current Flu H3N2 Epidemic 2Independent Results Show that BiondVax's Universal Flu Vaccine Administered in a Trial 3 Years ago Improves Immunogenicity Against Current Flu H3N2 Epidemic 3EnteroMedics Announces Appointment of Lori C. McDougal to the Board of Directors 2EnteroMedics Announces Appointment of Lori C. McDougal to the Board of Directors 3
Cached News: